These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 18495946

  • 1. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS, Aoki FY, Bow EJ.
    J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA, Chehata S, Amouri A, Bouaouina N, Chatti S, Saad A, Ennabli S.
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A, Rinaldi CR, Palmieri S, Cantore N, Mele G, Mettivier V, Miraglia E, Mastrullo L, Grimaldi F, Luciano L, Guerriero A, Rotoli B, Ferrara F.
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [Abstract] [Full Text] [Related]

  • 7. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Liu J, Mi Y, Fu M, Yu W, Wang Y, Lin D, Bian S, Wang J.
    Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acute adult leukemia. The Danbury Hospital experience.
    Provatas AC, Pezzimenti J, Cooper RB.
    Conn Med; 1988 Sep; 52(9):515-7. PubMed ID: 3180801
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preliminary results of an induction combination regimen including fractionated anthracycline.
    Krieger O, Bernhart M, Fiedler E, Kasparu H, Weber E, Lutz D.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610
    [No Abstract] [Full Text] [Related]

  • 17. Fetal liver infusion: an adjuvant in the therapy of acute myeloid leukemia (AML).
    Kochupillai V, Sharma S, Francis S, Mehra NK, Nanu A, Verma IC, Takkar D, Kumar S, Gokhale U.
    Prog Clin Biol Res; 1985 Dec; 193():267-79. PubMed ID: 3911212
    [No Abstract] [Full Text] [Related]

  • 18. Long term results in acute non-lymphocytic leukaemia.
    Saikia TK, Rajni A, Gopal R, Nair CN, Nadkarni KS, Kurkure PA, Pai VR, Pai SK, Advani SH.
    J Assoc Physicians India; 1988 Aug; 36(8):505-7. PubMed ID: 3073153
    [No Abstract] [Full Text] [Related]

  • 19. Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
    Battipaglia G, Avilia S, Morelli E, Caranci F, Perna F, Camera A.
    Ann Hematol; 2012 Aug; 91(8):1327-8. PubMed ID: 22237936
    [No Abstract] [Full Text] [Related]

  • 20. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor.
    Uhara H, Saida T, Nakazawa H, Ito T.
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S10-2. PubMed ID: 18625369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.